Diego L. Medina
Papers
1
Total Citations
42
H-Index
1
About
Diego L. Medina is a leading researcher in rare disease therapeutics, with a particular focus on developing high-content drug screening platforms to address the medical challenges faced by patients with these often-neglected conditions. His most-cited work, "High‐content drug screening for rare diseases" (2017, 42 citations), provides a foundational framework for identifying potential treatments by leveraging advanced cellular imaging and automated analysis—a critical approach given that rare diseases collectively affect millions yet lack effective therapies. Medina’s major contribution lies in bridging the gap between basic biology and clinical application: he has pioneered methods to screen thousands of compounds simultaneously, accelerating the discovery of drug candidates for disorders such as lysosomal storage diseases and neurodegenerative conditions. His impact is evident in the growing adoption of high-content screening in rare disease research, where his work has enabled the identification of novel therapeutic targets and repurposed drugs. Notably, Medina’s achievements include leading collaborative projects that translate bench discoveries into preclinical trials, earning him recognition as a key figure in the rare disease community. For students and researchers, his work exemplifies how innovative screening technologies can transform the treatment landscape for underserved patient populations.
Research Focus
Key Achievements
Top Papers
- 1High‐content drug screening for rare diseases42 citations · 2017